Circulating levels of resistin and risk of type 2 diabetes in men and women

Results from two prospective cohorts

Brian H. Chen, Yiqing Song, Eric L. Ding, Christian K. Roberts, Joann E. Manson, Nader Rifai, Julie E. Buring, J. Michael Gaziano, Simin Liu

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

OBJECTIVE - The purpose of this study was to investigate the role of circulating resistin levels in the development of type 2 diabetes using two prospective cohorts of well-characterized men and women. RESEARCH DESIGN AND METHODS - We conducted two prospective case-control studies nested in the Women's Health Study (WHS) and Physicians' Health Study II (PHS II). In the WHS, during a median of 10-years of follow-up, 359 postmenopausal women, who were apparently healthy at baseline and later developed type 2 diabetes, were prospectively matched with 359 healthy control subjects. In the PHS II, with 8 years of total follow-up, 170 men, who were apparently healthy at baseline and later developed type 2 diabetes, were matched with 170 healthy control subjects. Control subjects were matched by age, race, and time of blood draw. RESULTS - Resistin levels at baseline were significantly higher in women than in men (P = 0.003) and in case patients than in control subjects for both women (P < 0.001) and men (P = 0.07). After adjustment for matching factors, physical activity, alcohol intake, smoking, and family history of diabetes, the relative risk of type 2 diabetes comparing the highest to the lowest quartile of resistin in women was 2.22 ([95% CI 1.32-3.73]; P trend = 0.002). This association was attenuated after further adjustment for BMI (1.51 [0.86-2.65]; P trend = 0.20) or C-reactive protein (1.18 [0.68-2.07]; P trend = 0.60). A similar but weaker pattern was observed in men. CONCLUSIONS - Elevated levels of circulating resistin were significantly related to increased risk of type 2 diabetes, which appears to be partially accounted for by adiposity and the inflammatory process.

Original languageEnglish (US)
Pages (from-to)329-334
Number of pages6
JournalDiabetes Care
Volume32
Issue number2
DOIs
StatePublished - Feb 1 2009
Externally publishedYes

Fingerprint

Resistin
Type 2 Diabetes Mellitus
Women's Health
Healthy Volunteers
Women Physicians
Adiposity
Health
C-Reactive Protein
Case-Control Studies
Research Design
Smoking
Alcohols
Exercise
Physicians

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Circulating levels of resistin and risk of type 2 diabetes in men and women : Results from two prospective cohorts. / Chen, Brian H.; Song, Yiqing; Ding, Eric L.; Roberts, Christian K.; Manson, Joann E.; Rifai, Nader; Buring, Julie E.; Gaziano, J. Michael; Liu, Simin.

In: Diabetes Care, Vol. 32, No. 2, 01.02.2009, p. 329-334.

Research output: Contribution to journalArticle

Chen, BH, Song, Y, Ding, EL, Roberts, CK, Manson, JE, Rifai, N, Buring, JE, Gaziano, JM & Liu, S 2009, 'Circulating levels of resistin and risk of type 2 diabetes in men and women: Results from two prospective cohorts', Diabetes Care, vol. 32, no. 2, pp. 329-334. https://doi.org/10.2337/dc08-1625
Chen, Brian H. ; Song, Yiqing ; Ding, Eric L. ; Roberts, Christian K. ; Manson, Joann E. ; Rifai, Nader ; Buring, Julie E. ; Gaziano, J. Michael ; Liu, Simin. / Circulating levels of resistin and risk of type 2 diabetes in men and women : Results from two prospective cohorts. In: Diabetes Care. 2009 ; Vol. 32, No. 2. pp. 329-334.
@article{e1d7a11537f0473098bed10b0da47850,
title = "Circulating levels of resistin and risk of type 2 diabetes in men and women: Results from two prospective cohorts",
abstract = "OBJECTIVE - The purpose of this study was to investigate the role of circulating resistin levels in the development of type 2 diabetes using two prospective cohorts of well-characterized men and women. RESEARCH DESIGN AND METHODS - We conducted two prospective case-control studies nested in the Women's Health Study (WHS) and Physicians' Health Study II (PHS II). In the WHS, during a median of 10-years of follow-up, 359 postmenopausal women, who were apparently healthy at baseline and later developed type 2 diabetes, were prospectively matched with 359 healthy control subjects. In the PHS II, with 8 years of total follow-up, 170 men, who were apparently healthy at baseline and later developed type 2 diabetes, were matched with 170 healthy control subjects. Control subjects were matched by age, race, and time of blood draw. RESULTS - Resistin levels at baseline were significantly higher in women than in men (P = 0.003) and in case patients than in control subjects for both women (P < 0.001) and men (P = 0.07). After adjustment for matching factors, physical activity, alcohol intake, smoking, and family history of diabetes, the relative risk of type 2 diabetes comparing the highest to the lowest quartile of resistin in women was 2.22 ([95{\%} CI 1.32-3.73]; P trend = 0.002). This association was attenuated after further adjustment for BMI (1.51 [0.86-2.65]; P trend = 0.20) or C-reactive protein (1.18 [0.68-2.07]; P trend = 0.60). A similar but weaker pattern was observed in men. CONCLUSIONS - Elevated levels of circulating resistin were significantly related to increased risk of type 2 diabetes, which appears to be partially accounted for by adiposity and the inflammatory process.",
author = "Chen, {Brian H.} and Yiqing Song and Ding, {Eric L.} and Roberts, {Christian K.} and Manson, {Joann E.} and Nader Rifai and Buring, {Julie E.} and Gaziano, {J. Michael} and Simin Liu",
year = "2009",
month = "2",
day = "1",
doi = "10.2337/dc08-1625",
language = "English (US)",
volume = "32",
pages = "329--334",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "2",

}

TY - JOUR

T1 - Circulating levels of resistin and risk of type 2 diabetes in men and women

T2 - Results from two prospective cohorts

AU - Chen, Brian H.

AU - Song, Yiqing

AU - Ding, Eric L.

AU - Roberts, Christian K.

AU - Manson, Joann E.

AU - Rifai, Nader

AU - Buring, Julie E.

AU - Gaziano, J. Michael

AU - Liu, Simin

PY - 2009/2/1

Y1 - 2009/2/1

N2 - OBJECTIVE - The purpose of this study was to investigate the role of circulating resistin levels in the development of type 2 diabetes using two prospective cohorts of well-characterized men and women. RESEARCH DESIGN AND METHODS - We conducted two prospective case-control studies nested in the Women's Health Study (WHS) and Physicians' Health Study II (PHS II). In the WHS, during a median of 10-years of follow-up, 359 postmenopausal women, who were apparently healthy at baseline and later developed type 2 diabetes, were prospectively matched with 359 healthy control subjects. In the PHS II, with 8 years of total follow-up, 170 men, who were apparently healthy at baseline and later developed type 2 diabetes, were matched with 170 healthy control subjects. Control subjects were matched by age, race, and time of blood draw. RESULTS - Resistin levels at baseline were significantly higher in women than in men (P = 0.003) and in case patients than in control subjects for both women (P < 0.001) and men (P = 0.07). After adjustment for matching factors, physical activity, alcohol intake, smoking, and family history of diabetes, the relative risk of type 2 diabetes comparing the highest to the lowest quartile of resistin in women was 2.22 ([95% CI 1.32-3.73]; P trend = 0.002). This association was attenuated after further adjustment for BMI (1.51 [0.86-2.65]; P trend = 0.20) or C-reactive protein (1.18 [0.68-2.07]; P trend = 0.60). A similar but weaker pattern was observed in men. CONCLUSIONS - Elevated levels of circulating resistin were significantly related to increased risk of type 2 diabetes, which appears to be partially accounted for by adiposity and the inflammatory process.

AB - OBJECTIVE - The purpose of this study was to investigate the role of circulating resistin levels in the development of type 2 diabetes using two prospective cohorts of well-characterized men and women. RESEARCH DESIGN AND METHODS - We conducted two prospective case-control studies nested in the Women's Health Study (WHS) and Physicians' Health Study II (PHS II). In the WHS, during a median of 10-years of follow-up, 359 postmenopausal women, who were apparently healthy at baseline and later developed type 2 diabetes, were prospectively matched with 359 healthy control subjects. In the PHS II, with 8 years of total follow-up, 170 men, who were apparently healthy at baseline and later developed type 2 diabetes, were matched with 170 healthy control subjects. Control subjects were matched by age, race, and time of blood draw. RESULTS - Resistin levels at baseline were significantly higher in women than in men (P = 0.003) and in case patients than in control subjects for both women (P < 0.001) and men (P = 0.07). After adjustment for matching factors, physical activity, alcohol intake, smoking, and family history of diabetes, the relative risk of type 2 diabetes comparing the highest to the lowest quartile of resistin in women was 2.22 ([95% CI 1.32-3.73]; P trend = 0.002). This association was attenuated after further adjustment for BMI (1.51 [0.86-2.65]; P trend = 0.20) or C-reactive protein (1.18 [0.68-2.07]; P trend = 0.60). A similar but weaker pattern was observed in men. CONCLUSIONS - Elevated levels of circulating resistin were significantly related to increased risk of type 2 diabetes, which appears to be partially accounted for by adiposity and the inflammatory process.

UR - http://www.scopus.com/inward/record.url?scp=61849130650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61849130650&partnerID=8YFLogxK

U2 - 10.2337/dc08-1625

DO - 10.2337/dc08-1625

M3 - Article

VL - 32

SP - 329

EP - 334

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 2

ER -